Switching to second-line antiretroviral therapy in resource-limited settings: comparison of programmes with and without viral load monitoring.

Hdl Handle:
http://hdl.handle.net/10144/120708
Title:
Switching to second-line antiretroviral therapy in resource-limited settings: comparison of programmes with and without viral load monitoring.
Authors:
Keiser, Olivia; Tweya, Hannock; Boulle, Andrew; Braitstein, Paula; Schecter, Mauro; Brinkhof, Martin W G; Dabis, François; Tuboi, Suely; Sprinz, Eduardo; Pujades-Rodriguez, Mar; Calmy, Alexandra; Kumarasamy, Nagalingeswaran; Nash, Denis; Jahn, Andreas; MacPhail, Patrick; Lüthy, Ruedi; Wood, Robin; Egger, Matthias
Journal:
AIDS (London, England)
Abstract:
In high-income countries, viral load is routinely measured to detect failure of antiretroviral therapy (ART) and guide switching to second-line ART. Viral load monitoring is not generally available in resource-limited settings. We examined switching from nonnucleoside reverse transcriptase inhibitor (NNRTI)-based first-line regimens to protease inhibitor-based regimens in Africa, South America and Asia.
Affiliation:
Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.
Issue Date:
10-Sep-2009
URI:
http://hdl.handle.net/10144/120708
DOI:
10.1097/QAD.0b013e32832e05b2
PubMed ID:
19531928
Language:
en
ISSN:
1473-5571
Appears in Collections:
HIV/AIDS

Full metadata record

DC FieldValue Language
dc.contributor.authorKeiser, Oliviaen
dc.contributor.authorTweya, Hannocken
dc.contributor.authorBoulle, Andrewen
dc.contributor.authorBraitstein, Paulaen
dc.contributor.authorSchecter, Mauroen
dc.contributor.authorBrinkhof, Martin W Gen
dc.contributor.authorDabis, Françoisen
dc.contributor.authorTuboi, Suelyen
dc.contributor.authorSprinz, Eduardoen
dc.contributor.authorPujades-Rodriguez, Maren
dc.contributor.authorCalmy, Alexandraen
dc.contributor.authorKumarasamy, Nagalingeswaranen
dc.contributor.authorNash, Denisen
dc.contributor.authorJahn, Andreasen
dc.contributor.authorMacPhail, Patricken
dc.contributor.authorLüthy, Ruedien
dc.contributor.authorWood, Robinen
dc.contributor.authorEgger, Matthiasen
dc.date.accessioned2011-01-31T14:57:52Z-
dc.date.available2011-01-31T14:57:52Z-
dc.date.issued2009-09-10-
dc.identifier.citationSwitching to second-line antiretroviral therapy in resource-limited settings: comparison of programmes with and without viral load monitoring. 2009, 23 (14):1867-74 AIDSen
dc.identifier.issn1473-5571-
dc.identifier.pmid19531928-
dc.identifier.doi10.1097/QAD.0b013e32832e05b2-
dc.identifier.urihttp://hdl.handle.net/10144/120708-
dc.description.abstractIn high-income countries, viral load is routinely measured to detect failure of antiretroviral therapy (ART) and guide switching to second-line ART. Viral load monitoring is not generally available in resource-limited settings. We examined switching from nonnucleoside reverse transcriptase inhibitor (NNRTI)-based first-line regimens to protease inhibitor-based regimens in Africa, South America and Asia.en
dc.language.isoenen
dc.rightsPublished by Wolters Kluwer Lippincott Williams & Wilkins - Archived on this site by kind permission Wolters Kluweren
dc.subject.meshAdolescenten
dc.subject.meshAdulten
dc.subject.meshAnti-HIV Agentsen
dc.subject.meshAntiretroviral Therapy, Highly Activeen
dc.subject.meshCD4 Lymphocyte Counten
dc.subject.meshDeveloping Countriesen
dc.subject.meshDrug Monitoringen
dc.subject.meshFemaleen
dc.subject.meshHIV Infectionsen
dc.subject.meshHIV Protease Inhibitorsen
dc.subject.meshHIV-1en
dc.subject.meshHumansen
dc.subject.meshMaleen
dc.subject.meshMedically Underserved Areaen
dc.subject.meshMiddle Ageden
dc.subject.meshReverse Transcriptase Inhibitorsen
dc.subject.meshTime Factorsen
dc.subject.meshTreatment Failureen
dc.subject.meshViral Loaden
dc.subject.meshYoung Adulten
dc.titleSwitching to second-line antiretroviral therapy in resource-limited settings: comparison of programmes with and without viral load monitoring.en
dc.contributor.departmentInstitute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.en
dc.identifier.journalAIDS (London, England)en

Related articles on PubMed

All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.